Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma

This study has been terminated.
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Gynecologic Oncology Associates Identifier:
First received: September 10, 2009
Last updated: March 9, 2015
Last verified: March 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2012
  Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)